Tom Wilton
Corporate Officer/Principal bei CARISMA THERAPEUTICS, INC.
Aktive Positionen von Tom Wilton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2019 | - |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Karriereverlauf von Tom Wilton
Ausbildung von Tom Wilton
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- Tom Wilton
- Erfahrung
